Journey Medical DERM
NASDAQ DERM
$4.89 -0.33 (-6.32%)
As of: Oct 21, 2026 · 3:06 PM EDT

Journey Medical (DERM) Raw Materials (2021)

Updated

Journey Medical (DERM) recorded Raw Materials of $5.57 million in Q4 2021, up 2.2% from the prior quarter.

Analysis

Journey Medical (DERM) Raw Materials (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Journey Medical 134.86 Mn 32.95 Mn 12.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 5.57 Mn
Sep 30, 2021 5.45 Mn
API Access

Journey Medical Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=DERM&period=max&api_key=YOUR_API_KEY